Targeting muscle cells' insulin receptors allows more efficient gene therapy Method could allow significant dosage reduction, addressing key concerns, scientists find.
December 30, 2020
JUPITER, FL The potential for gene therapy to address genetic diseases is immense, but several challenges have held up progress. Improving the efficiency of the gene delivery system could be a viable way to resolve many of them, says Scripps Research, Florida virologist Hyeryun Choe, PhD.
In a paper published in the open access journal Molecular Therapy: Methods & Clinical Development, Choe and colleagues report a more productive method of introducing therapeutic genes: by programming the gene therapy vector to seek out muscle cells, via abundant insulin receptors displayed on the surface of those cells.
The most-studied method of gene therapy has issues of excessive cost and high dose-associated toxicity risks, Choe explains. Lowering the dose needed to bring about the desired treatment should ease both problems, she explains. To accomplish this, Choe and graduate trainee Cody Jackson sought to engineer a viral gene delivery system to target muscle cells. They reasoned that muscle cells' longevity, among other traits, would make them the best cells for the job.
Muscle cells don't divide, so you have them for your whole life, Choe says.
One of the ways scientists administer therapeutic genes is by engineering viruses to deliver them into cells. They start with a benign virus, such as the adeno-associated virus, or AAV, which doesn't replicate in humans, and reengineer its genome to carry the genetic payload needed to treat or prevent disease.
The virus can be altered to display a protein fragment perfectly structured to bind to a desired cell receptor, so that it unlocks entry to a specific cell type, like a key made for one specific type of lock. The next challenge Choe's team faced was to identify the most promising receptor on muscle cells, and find the right peptide or protein fragment, that would bind tightly to that receptor.
The protein fragment that Choe's team identified recognizes muscle cells' insulin receptors with high affinity, explains Jackson. They found the introduction of that insulin-mimetic peptide boosted the efficiency of vector uptake by nearly twentyfold compared to standard methods, thus allowing a significantly lower dose of the therapeutic virus to deliver a gene of interest. It showed that muscle cells are very good targets for gene therapy, says Jackson.
Something unique about muscle tissue is its capillary network. It allows the proteins produced there to easily diffuse into the blood, Jackson explains. This platform could be used for any disease where you want the protein to be circulating throughout the body, systemically.
They checked whether the use of a vector targeting insulin receptor could impact the blood sugar of treated animals. Testing proved it did not, he adds.
The U.S. Food and Drug Administration has so far approved gene therapies for an eye condition that causes congenital blindness, and a genetic disease called spinal muscular atrophy. The treatments are life-changing, but can cost between $500,000 and $2 million per patient.
With enhanced efficiency, doses can be lowered, and with lowered doses, costs and toxicity-related adverse events can be reduced, Choe says.
Choe says the insulin receptor-targeting strategy is useful for another reason. Because the insulin receptor they targeted is conserved across multiple animal species, the potential new therapies can easily be evaluated in laboratory animals.
It's clear that targeting muscle cells via insulin receptors represents an important improvement in gene therapy technology, and offers potential routes to address both genetic and infectious diseases, such as HIV, for which neutralizing antibodies are often produced via an intramuscular delivery of an AAV vector, says Choe.
This approach worked like a charm, she says.
Jackson's work on the study earned him the cover image for the scientific journal. Conducted as part of his PhD thesis project, it also helped him become the first student to complete his doctorate through the joint MD/PhD program offered cooperatively by the Scripps Research, Florida branch of the Skaggs Graduate School of Chemical and Biological Sciences, and Florida Atlantic University's Charles E. Schmidt College of Medicine.
The rigorous joint-degree program demands real commitment, Jackson acknowledged. It requires a bachelor's degree plus two years of medical school coursework, followed by four to five years of doctoral studies in Scripps Research labs. But that's not the end of it. Another two years of clinical rotations are required to earn the white coat and the letters MD. He'll start his clinical rotations this spring.
I am hoping that completing the training in both programs means the opportunities will be open for me to do clinical practice, or research, or both, Jackson says.
Skaggs Graduate School Associate Dean Christoph Rader, PhD, praised Jackson's hard work and impact.
We were fortunate to recruit Cody Jackson to our joint MD/PhD program. His dedication and drive have been outstanding, Rader says. As our first graduate, he will always be remembered.
In addition to Jackson and Choe, the study's authors include Michael Farzan, Audrey Richard and Amrita Ojha of Scripps Research; Kimberly Conkright, Jeffrey Trimarchi, Charles Bailey and Michael Alpert of Emmune, Inc.; and Mark Kay of Stanford University.
This study was supported by grants from the National Institutes of Health, including R37 AI091476, R44 AI134269 and R44 TR003501.
Immunology & Microbiology Choe, Hyeryun
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
13/05/2026
New Adobe Premiere Color Grading Mode Accelerated on NVIDIA GPUs
Joel Pennington May 13, 2026
0 Comments
New NVIDIA RTX-accelerated features streamlin...
13/05/2026
Grass Valley announced that dB Broadcast has delivered new IP-based outside broadcast (OB) trucks for Cloudbass, featuring Grass Valley LDX 100 Series cameras a...
13/05/2026
Ikegami will exhibit the latest additions to its wide range of broadcast production cameras, control units, viewfinders and monitors on stand 5D3-1 at Broadcast...
13/05/2026
FISE, working with the founding members of the XR Sports Alliance (XRSA), Accedo, Qualcomm Technologies, Inc. and HBS, have collaborated to develop an immersive...
13/05/2026
Canon Unveils New EOS R6 V Full-Frame EOS Camera and RF20-50mm F4 L IS USM PZ Bu...
13/05/2026
Boston Conservatory at Berklee Honors Beth Morrison and Moses Pendleton at Comme...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Creative software developer Foundry today announced the latest developments on Nuke Stage. A purpose-built application for end-to-end virtual production and in-...
13/05/2026
A definitive portrait of one of Ireland's most influential musicians
New TV documentary airs Monday 18 May on RT One and RT Player at 9.35pm
Watch the...
13/05/2026
Agentic AI is changing the way users get work done. Following the success of OpenClaw, the community is embracing new open source agentic frameworks. The latest...
13/05/2026
Reinforcement-learning agents - AI systems that learn by trial and error - can c...
12/05/2026
Beyond the Hype: A Strategic Post-Hoc Analysis of NAB 2026 If NAB Show 2026 had an underlying theme, it was a quiet, industry-wide pivot from the high-energy sp...
12/05/2026
Guntermann and Drunck (G&D), a Panoptec Technologies Group company, and CT Square, led by Chandresh Shah, have announced a joint venture to distribute G&D and V...
12/05/2026
With 30 days until the start of the FIFA World Cup 2026, Telemundo, the exclusive Spanish-language home of the tournament in the United States, has announced th...
12/05/2026
The NHL has announced the return of Stanley Pup for its third consecutive year, a 90-minute special featuring adoptable rescue dogs competing on a miniature rin...
12/05/2026
NBCUniversal presented its 2026 Upfront to advertisers at Radio City Music Hall, detailing upcoming programming across NBC, Peacock, Bravo, and Versant properti...
12/05/2026
FOX Sports has announced funding for the Fandom and Social Connection Initiative at Harvard Kennedy School's Shorenstein Center on Media, Politics, and Publ...
12/05/2026
TNDV and Live Media, both divisions of Live Media Group, supported live broadcast coverage around NCAA Final Four weekend in Indianapolis, including the March M...
12/05/2026
The European Football Alliance (EFA) has announced a content distribution agreement with Fubo Sports Network, the free ad-supported streaming TV (FAST) channel ...
12/05/2026
For the first time, Spanish-speaking fans in the U.S. will have two separate tel...
12/05/2026
CP Communications led a comprehensive spectrum management initiative on behalf of Churchill Downs during Kentucky Derby week, coordinating RF assets across the ...
12/05/2026
LiveU has announced a strategic partnership with DRONERESPONDERS, a 501(c)3 non-...
12/05/2026
Open Broadcast Systems has announced that BMC TV, a specialist in IP transport of broadcast content, has selected the Open Broadcast Systems 5G Flyaway solution...
12/05/2026
NEP Europe, part of NEP Group, has announced it will deliver broadcast solutions...
12/05/2026
Grass Valley has announced continued collaboration with Ravensbourne University ...
12/05/2026
Stats Perform has announced the launch of Opta Pulse, an AI-assisted video creation and distribution platform for leagues, rights holders, and broadcasters. The...
12/05/2026
FOX Sports has announced a collaboration with Sesame Workshop to integrate Sesame Street characters into FOX Sports' FIFA World Cup 2026 programming. Conten...
12/05/2026
To date, NHL Productions has produced 19 broadcasts with commentary in American Sign Language
NHL in ASL (American Sign Language) may be just one show, but the...
12/05/2026
Google's Brian Albert: creators, athletes, highlights, nostalgia, second-scr...
12/05/2026
A still from Past Lives by Celine Song, an official selection of the Premieres program at the 2023 Sundance Film Festival. (Courtesy of Sundance Institute | p...
12/05/2026
Spotify is where fans and artists come together, turning discovery into somethin...
12/05/2026
Features patented Marco-MMC clocking technology
Black Lion Audio's latest release combines the company's expertise in clocking with their renowned p...
12/05/2026
New Track Panel, sequencer upgrades & more
Following their recent public beta release, Reason Studios have announced the full release of Reason 14. With the...
12/05/2026
One month to go! SBS reveals expansive FIFA World Cup 2026 lineup beyond the pi...
12/05/2026
Rohde & Schwarz presents its advanced solutions for power electronics testing at...
12/05/2026
aconnic AG (ISIN: DE000A0LBKW6), Munich, has developed a modified fund raising p...
12/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/05/2026
Tyrell Corporation, specialists in high-end live sports and entertainment broadcasts, was tasked with delivering compelling broadcast coverage of premier equest...
12/05/2026
Registration is now open for IBC2026 as the global media, entertainment and technology community prepares to converge on the RAI Amsterdam from 11 14 September ...
12/05/2026
Ross Video, a global leader in live video production technology, will present its latest innovations and integrated production workflows at BroadcastAsia 2026, ...
12/05/2026
500 selected leaders from around the world across start-ups, corporates, and venture capital. Over 50bn in assets under management among attending investors, a...
Targeting muscle cells' insulin receptors allows more efficient gene therapy Method could allow significant dosage reduction, addressing key concerns, scientists find.
